Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Change in Inventory (2020 - 2025)

Sanara MedTech (SMTI) has disclosed Change in Inventory for 9 consecutive years, with -$8278.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Inventory rose 98.2% year-over-year to -$8278.0, compared with a TTM value of $1.0 million through Sep 2025, up 170.14%, and an annual FY2024 reading of -$1.4 million, down 193.36% over the prior year.
  • Change in Inventory was -$8278.0 for Q3 2025 at Sanara MedTech, down from $525147.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $1.0 million in Q2 2023 and bottomed at -$500149.0 in Q2 2024.
  • Average Change in Inventory over 5 years is $152322.5, with a median of $65433.0 recorded in 2022.
  • The sharpest move saw Change in Inventory surged 2474.84% in 2023, then tumbled 353.01% in 2024.
  • Year by year, Change in Inventory stood at $640844.0 in 2021, then crashed by 89.79% to $65433.0 in 2022, then crashed by 282.44% to -$119375.0 in 2023, then increased by 24.76% to -$89821.0 in 2024, then soared by 90.78% to -$8278.0 in 2025.
  • Business Quant data shows Change in Inventory for SMTI at -$8278.0 in Q3 2025, $525147.0 in Q2 2025, and $605628.0 in Q1 2025.